Ablative techniques in colorectal liver metastases: A systematic review, descriptive summary of practice, and recommendations for optimal data reporting

被引:0
作者
Ng, Wee Han [1 ]
Machado, Catarina [1 ]
Rooney, Alice [1 ]
Jones, Robert [5 ]
Rees, Jonathan [1 ,2 ,3 ]
Pathak, Samir [4 ]
机构
[1] Univ Bristol, Bristol Med Sch, Bristol, England
[2] Univ Hosp Bristol, Dept Pancreat & Hepatobiliary Surg, Bristol, England
[3] Weston NHS Fdn Trust, Bristol, England
[4] Leeds Teaching Hosp NHS Trust, Dept Pancreat Surg, Leeds, England
[5] Hepatobiliary Surg Liverpool Univ Hosp NHS Fdn Tru, Liverpool, England
来源
EJSO | 2025年 / 51卷 / 02期
关键词
LAPAROSCOPIC RADIOFREQUENCY ABLATION; PERCUTANEOUS MICROWAVE ABLATION; LONG-TERM OUTCOMES; THERMAL ABLATION; PROGNOSTIC-FACTORS; HEPATIC RESECTION; SURVIVAL; CANCER; RECURRENCE; CHEMOTHERAPY;
D O I
10.1016/j.ejso.2024.109487
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Radiofrequency Ablation (RFA) and Microwave Ablation (MWA) are alternative treatments for colorectal liver metastasis (CRLM) patients that are unsuitable for resection. However, consensus is lacking regarding selection criteria, tumour characteristics, ablation technique delivery, and device settings. This study aims to summarise current evidence to inform future prospective studies. Methods: A systematic review was conducted following PRISMA guidelines. Studies assessing RFA and MWA treatment of CRLM were identified in Medline, Embase, Web of Science and the Cochrane database of systematic reviews, from inception until 31st August 2024. Results: Fifty-two studies were included (retrospective cohort n = 45, prospective cohort n = 5, non-randomized comparative studies n = 2). Fifty-four inclusion criteria were used across 45 studies and were not stated in 7 studies. Tumours varied in mean number [1-8] and diameter (1.54-4.35 cm). Neoadjuvant chemotherapy use (10-100 % of patients), ablation delivery approach (open n = 4, laparoscopic n = 11, percutaneous n = 26, mixed n = 5), anaesthetic mode (GA n = 18, LA n = 11, mixed n = 2) and delivering clinician (radiologist n = 11, surgeon n = 16, both n = 1) all varied. Thirty-two studies lacked complete ablation device settings. Six studies followed a standardized ablation algorithm and 14 studies had specific settings. Five-year survival ranged from 0 to 69.7 % for ablation. Conclusions: There is significant heterogeneity in the reporting of study design, patient selection, and ablation techniques for CRLM. The lack of standardized approaches and inconsistent reporting of methodology and outcomes make it challenging to determine the optimal ablative treatment for CRLM. We recommend that future research should focus on clearly defining selection and treatment criteria, as well as treatment delivery.
引用
收藏
页数:13
相关论文
共 81 条
[31]  
Lee Kwan Ho, 2012, Korean J Gastroenterol, V59, P218
[32]   Survival and Prognostic Factors of Colorectal Liver Metastases After Surgical and Nonsurgical Treatment [J].
Lemke, Johannes ;
Cammerer, Gregor ;
Ganser, Johannes ;
Scheele, Jan ;
Xu, Pengfei ;
Sander, Silvia ;
Henne-Bruns, Doris ;
Kornmann, Marko .
CLINICAL COLORECTAL CANCER, 2016, 15 (04) :E183-E192
[33]   Thermal ablation with and without adjuvant systemic therapy: a nationwide multicenter observational cohort study of solitary colorectal liver metastases [J].
Li, Jianming ;
Pang, Chuan ;
Liu, Guangjian ;
Xie, Xiaoyan ;
Zhang, De-zhi ;
Li, Kai ;
Li, Zhishuai ;
He, Guangbin ;
Xu, Erjiao ;
Zhong, Huage ;
Yang, Hong ;
Lu, Man ;
Lou, Kexin ;
Xie, Xiang ;
Lan, Sirong ;
Li, Qian ;
Dai, Guanghai ;
Yu, Jie ;
Liang, Ping .
INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (07) :4240-4248
[34]   Phase II/III Study of Radiofrequency Ablation Combined with Cytokine-Induced Killer Cells Treating Colorectal Liver Metastases [J].
Li, Xiaodong ;
Dai, Xichao ;
Shi, Liangrong ;
Jiang, Yong ;
Chen, Xuemin ;
Chen, Lujun ;
Zhao, Jiemin ;
Qiang, Weiguang ;
Wu, Jun ;
Ji, Mei ;
Jiang, Jingting ;
Wu, Changping .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 40 (1-2) :137-145
[35]  
Liberati A., BMJ, V339, pb2700, DOI DOI 10.1136/BMJ.B2700
[36]   Surgery versus thermal ablation for small-size colorectal liver metastases (COLLISION): An international, multicenter, phase III randomized controlled trial. [J].
Meijerink, Martijn Ruben ;
van der Lei, Susan ;
Dijkstra, Madelon ;
Versteeg, Kathelijn S. ;
Buffart, Tineke E. ;
Lissenberg-Witte, Birgit I. ;
Swijnenburg, Rutger-Jan ;
van den Tol, M. Petrousjka ;
Puijk, Robbert S. .
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17_SUPPL) :LBA3501-LBA3501
[37]   Radiofrequency Ablation to Improve Survival After Conversion Chemotherapy for Colorectal Liver Metastases [J].
Nielsen, Karin ;
Scheffer, Hester J. ;
Volders, Jose H. ;
van der Vorst, Maurice J. D. L. ;
van Tilborg, Aukje A. J. M. ;
Comans, Emile F. I. ;
de Lange-de Klerk, E. S. M. ;
Sietses, Colin ;
Meijer, Sybren ;
Meijerink, Martijn R. ;
van den Tol, M. Petrousjka .
WORLD JOURNAL OF SURGERY, 2016, 40 (08) :1951-1958
[38]   Incidence and Treatment of Local Site Recurrences Following RFA of Colorectal Liver Metastases [J].
Nielsen, Karin ;
van Tilborg, Aukje A. J. M. ;
Meijerink, Martijn R. ;
Macintosh, Matessa O. ;
Zonderhuis, Babs M. ;
de Lange, Elly S. M. ;
Comans, Emile F. I. ;
Meijer, Sybren ;
van den Tol, M. Petrousjka .
WORLD JOURNAL OF SURGERY, 2013, 37 (06) :1340-1347
[39]   Comparison between Percutaneous Radiofrequency Ablation and Surgical Hepatectomy Focusing on Local Disease Control Rate for Colorectal Liver Metastases [J].
Nishiwada, Satoshi ;
Ko, Saiho ;
Mukogawa, Tomohide ;
Ishikawa, Hirofumi ;
Matsusaka, Masanori ;
Nakatani, Toshiya ;
Kikuchi, Eiryo ;
Watanabe, Akihiko .
HEPATO-GASTROENTEROLOGY, 2014, 61 (130) :436-441
[40]  
Nouso K, 2010, HEPATO-GASTROENTEROL, V57, P117